Our Company

BD can help you improve surgical outcomes and lower costs Surgical efficiency, patient safety and outcomes, procedural cost management BD can help you identify potential “at-risk” patients, empower clinical intervention, and advance health system insights BD can help you optimize clinical effectiveness to help drive improvement in patient outcomes

The company’s line of plastic conical screwtop test tubes, known as ‘Falcon tubes’, is popular and the term is sometimes used as a generic term for such tubes. In certain places, BD Medical also offers consulting and analytics related services. In 2024, BD announced it would acquire Edwards Lifesciences’ critical care unit for $4.2 billion.

Sign Up for Job Alerts

• 1955 BD begins using AMI of France to manufacture steel tubes for hypodermic needles.
• Surgical efficiency, patient safety and outcomes, procedural cost management
• Our Purpose drives us to create innovative solutions that make a meaningful impact on advancing the world of health™.
• In October 2014, the company agreed to acquire CareFusion for a price of US$12.2 billion in cash and stock.
• 2015 BD became the first to integrate IV pumps with electronic health records.

1940 BD launched the first sterilization technology for devices. 1947 BD hired Joseph Kleiner, who brings his multi-fit syringe and his idea for the evacuated tube. 1948 BD founders turn over the company to their sons. 1956 BD enters the Brazilian syringe market and quickly becomes the largest provider in the country with krikya-online.com/ two modern plants and HQ in Sao Paulo. 1955 BD begins using AMI of France to manufacture steel tubes for hypodermic needles.

Q-Syte Luer and IV Catheter partial recall

“Jack” Howe joins BD and becomes integral to developing sterility control procedures and refining the process for manufacturing disposable syringes and needles. 1962 BD launched the first mass production of syringes and needles. 2007 BD participates in PEPFAR, the U.S. government’s global effort to combat HIV and the largest global health program devoted to a single disease.

BD Medical’s Consulting services are primarily targeted at hospitals, healthcare systems and networks of healthcare providers.citation needed Quality of care, cost efficiency, healthcare worker and patient safety and experience Medical Essentials forms the foundation of health care delivery, producing billions of devices each year that ensure safe medication administration and support accurate diagnostics. 1913 BD merged with Oscar O.R. Schwidetzky’s surgical import company, bringing his Asepto™ bulb syringe along with helping to develop the American-made ACE® bandage.

Through continuous innovation and strategic leadership, we empower biopharma partners to launch faster, grow reliably, and deliver better outcomes. 1898 BD acquired its first patent for an all-glass syringe. “Doc” Fleischer, developer of the mercurial sphygmomanometer, merged his company with BD.

In July 2021, BD announced it would acquire surgical scaffold maker Tepha, after having acquired Velano Vascular earlier the same month. This agreement protects patents and intellectual properties of both companies ensuring the quality and integrity of Embecta Corporation’s cannulas used in their products. The transaction was completed later that year, and the company became a wholly-owned subsidiary of BD, rebranded as Bard.